Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

239.56
BATS BZX Real-Time Price
As of 12:25pm ET
 -4.38 / -1.80%
Today’s Change
195.50
Today|||52-Week Range
322.68
-23.34%
Year-to-Date
The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and G...
10:02am / Zacks.com - Paid Partner Content
My Takeaways and Observations
Sep 20 / TheStreet.com - Paid Partner Content
Allergan Gets FDA Approval for New Line of Breast Implants
9:17am / Zacks.com - Paid Partner Content
Wall Street Creeps Higher Ahead of Fed Decision
Sep 20 / TheStreet.com - Paid Partner Content
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
7:41am / Zacks.com - Paid Partner Content
Why Tobira Therapeutics Inc Was an Overnight Octuple
Sep 20 / MotleyFool.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
Sarepta jumps after drugs regulator boost
Sep 20 / FT.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Stocks Post Modest Gains as Fed Meets, Crude Higher
Sep 20 / TheStreet.com - Paid Partner Content
ETFs in Focus on the Nasdaq Rally
Sep 23 / Zacks.com - Paid Partner Content
Allergan's Chart Is Not Persuasive
Sep 20 / TheStreet.com - Paid Partner Content
Allergan/Adamas Launch New Dosage Strengths of Namzaric
Sep 23 / Zacks.com - Paid Partner Content
More Squawk from Jim Cramer: Allergan (AGN) Buying Tobira (TBRA) Looks Like 'Such an ...
Sep 20 / TheStreet.com - Paid Partner Content
US politicians lament inaction over price-gouging drug companies
Sep 23 / FT.com - Paid Partner Content
Allergan (AGN) Stock Down After Tobira Therapeutics Deal
Sep 20 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
Stocks Rise as Wall Street Looks to Fed's Decision on Interest Rates
Sep 20 / TheStreet.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
Applied Genetic Technologies Is an Attractive Acquisition Target for Allergan or Biog...
Sep 20 / TheStreet.com - Paid Partner Content
Wallace Weitz's Largest 2nd-Quarter Trades
Sep 22 / GuruFocus News - Paid Partner Content
Jeff Auxier Buys Biogen, LyondellBasell and Union Pacific
Sep 19 / GuruFocus News - Paid Partner Content
The Good, the Bad and the Ugly in Today's Market
Sep 22 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data
Sep 16 / Zacks.com - Paid Partner Content
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Stock Market News for September 15, 2016
Sep 15 / Zacks.com - Paid Partner Content
Is Galectin The Next Takeover Target for the Biotech World?
Sep 22 / Zacks.com - Paid Partner Content
Company News for September 15, 2016
Sep 15 / Zacks.com - Paid Partner Content
Jim Cramer's Top Takeaways: Flex, Walt Disney, Allergan
Sep 22 / TheStreet.com - Paid Partner Content
Allergan to Buy Vitae Pharma to Boost Dermatology Suite
Sep 15 / Zacks.com - Paid Partner Content
Allergan's Boldness may not be Limited to Tobira Deal
Sep 21 / TheStreet.com - Paid Partner Content
What Happened in the Stock Market Today
Sep 14 / MotleyFool.com - Paid Partner Content
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sep 21 / Zacks.com - Paid Partner Content
Coach slips on 'unhealthy manner' warning
Sep 14 / FT.com - Paid Partner Content
Stock Market News for September 21, 2016
Sep 21 / Zacks.com - Paid Partner Content
Bayer Monsanto deal requires jumbo financing
Sep 14 / FT.com - Paid Partner Content
Stock Futures Rise as Bank of Japan Tackles Deflation
Sep 21 / TheStreet.com - Paid Partner Content
Here's Why Shares of Vitae Pharmaceuticals Inc Are Skyrocketing Today
Sep 14 / MotleyFool.com - Paid Partner Content
Allergan Buys NASH Therapy Maker Tobira at Huge Premium
Sep 21 / Zacks.com - Paid Partner Content
Bayer Finally Buys Monsanto, Inflation Vanishes
Sep 14 / Zacks.com - Paid Partner Content
Why Did Tobira Therapeutics (TBRA) Stock Skyrocket 720% Today?
Sep 20 / Zacks.com - Paid Partner Content
Why Allergan Should Start Paying a Dividend
Sep 13 / MotleyFool.com - Paid Partner Content
Why DTS, SolarCity, and Tobira Therapeutics Jumped Today
Sep 20 / MotleyFool.com - Paid Partner Content
'Middlemen' under the spotlight in EpiPen furore
Sep 09 / FT.com - Paid Partner Content
How Will Allergan (AGN) Stock React to Akarna Therapeutics Deal?
Sep 20 / TheStreet.com - Paid Partner Content
CEO of Botox maker vows to limit price hikes
Sep 07 / CNNMoney.com